Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.36
(-1.37%)
HKD 0.36
(-1.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 74.75 Million CNY | -42.51% |
| 2022 | 130.02 Million CNY | 11.12% |
| 2021 | 117.01 Million CNY | 26.43% |
| 2020 | 92.56 Million CNY | 38.55% |
| 2019 | 66.8 Million CNY | 0.88% |
| 2018 | 66.22 Million CNY | 75.9% |
| 2017 | 37.76 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | 50 Million HKD | 0.0% |
| 2023 FY | - CNY | -42.51% |
| 2023 Q4 | 33.04 Million HKD | 0.0% |
| 2022 FY | - CNY | 11.12% |
| 2022 Q4 | 72.67 Million HKD | 0.0% |
| 2022 Q2 | 84.54 Million HKD | 0.0% |
| 2021 Q2 | 73.38 Million HKD | 0.0% |
| 2021 FY | - CNY | 26.43% |
| 2021 Q4 | 66.81 Million HKD | 0.0% |
| 2020 Q4 | 18.16 Million CNY | 0.1% |
| 2020 Q3 | 18.14 Million CNY | 0.0% |
| 2020 FY | - CNY | 38.55% |
| 2019 Q4 | 9.01 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.88% |
| 2018 FY | - CNY | 75.9% |
| 2017 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 8.53 Billion HKD | 99.124% |